Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
3 Unusual Insider Transactions you Should Know About
03:22pm, Wednesday, 13'th Aug 2025
While no single indicator can guarantee a stock's performance, the pattern of insider transactions can provide a powerful glimpse into a company's prospects.
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?
01:46pm, Wednesday, 13'th Aug 2025
HIMS records subscriber surge and revenue growth in second-quarter 2025, but rising costs strain gross margins.
SAN FRANCISCO, Aug. 13, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower
NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). S
HIMS stock monster insider trading alert
03:04am, Wednesday, 13'th Aug 2025
Hims & Hers Health (NYSE: HIMS) Chief Executive Officer Andrew Dudum has offloaded a massive block of company shares, marking the largest insider transaction since the firm went public.
NEW YORK and NEW ORLEANS, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they h
Hims & Hers CEO sells $33 million in stock after a massive rally
03:21pm, Tuesday, 12'th Aug 2025
The company says the sales came from indirect holdings and were for “tax and philanthropic purposes.”
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care
01:16pm, Tuesday, 12'th Aug 2025
HIMS leverages its consumer-first telehealth model, AI-driven personalization and global expansion plans to outpace industry growth.
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health
12:48pm, Tuesday, 12'th Aug 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Hims To Contact Him Directly To Discuss Their Options
LOS ANGELES, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the class action filed on behal
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. (NYSE: HIMS) between April 29, 2025 a
Bragar Eagel & Squire, P.C. Litigation Partners Brandon Walker and Marion Passmore Encourage Investors Who Suffered Losses In Hims To Contact Them To Discuss Their Options
SAN FRANCISCO, Aug. 11, 2025 (GLOBE NEWSWIRE) -- On August 5, 2025, investors in Hims & Hers Health (NYSE: HIMS) declined almost 11% in another sell-off after the company disclosed that it would lower
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers Health, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
04:26pm, Monday, 11'th Aug 2025
NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Hims & Hers Health, Inc. ("Hims & Hers Health, Inc." or the "Company") (NYSE: HIMS) of a class action securities
Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies?
03:51pm, Monday, 11'th Aug 2025
In Novo Nordisk's legal fight against dozens of U.S. pharmacies and companies selling cheaper copies of its weight-loss drug Wegovy, one name remains conspicuously absent: Hims & Hers. The high-profil
